Melatonin

Verify with FDA CVM →

236 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
236
Total Reports
29
Deaths Reported
1230.0%
Death Rate

Active Ingredients

Melatonin

Administration Routes

OralUnknownSubcutaneous

Species Affected

Dog 231
Cat 2
Human 2
Pig 1

Most Affected Breeds

Retriever - Labrador 28
Boxer (German Boxer) 14
Shih Tzu 10
Spitz - German Pomeranian 9
Crossbred Canine/dog 8
Chihuahua 7
Maltese 7
Dachshund (unspecified) 7
Shepherd Dog - German 6
Bulldog 6

Most Reported Reactions

Diarrhoea 35
Vomiting 32
Lethargy (see also Central nervous system depression in 'Neurological') 28
Decreased appetite 23
Polydipsia 22
Death by euthanasia 21
Polyuria 20
Weight loss 20
Other abnormal test result NOS 20
Anorexia 20
Elevated alanine aminotransferase (ALT) 18
Emesis 17

Outcome Breakdown

Ongoing
80 (33.9%)
Outcome Unknown
66 (28.0%)
Recovered/Normal
59 (25.0%)
Euthanized
20 (8.5%)
Died
9 (3.8%)
Recovered with Sequela
2 (0.8%)

Data Summary

Metric Value
Total adverse event reports 236
Reports involving death 29
Case-fatality rate (reported events) 1230.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Melatonin Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 236 adverse event reports referencing Melatonin, including 29 reports in which the animal died — a 1230.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Melatonin. Reported administration routes include Oral, Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Melatonin reports are Dog (231 reports), Cat (2 reports), Human (2 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (28), Boxer (German Boxer) (14), Shih Tzu (10) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Melatonin are Diarrhoea (35), Vomiting (32), Lethargy (see also Central nervous system depression in 'Neurological') (28), Decreased appetite (23). Of the 236 reports with a coded outcome, Ongoing is the leading category at 33.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Melatonin.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial